磁性括约肌增强术与胃底折叠术治疗食管裂孔疝相关反流的中期结局:282例倾向性评分匹配比较
该回顾性单中心研究对141例磁性括约肌增强术(MSA)与141例Nissen胃底折叠术患者进行倾向性评分匹配,平均随访3.9年。MSA组年手术翻修风险显著低于胃底折叠术(1.2% vs 3.0%/年;HR 0.38;95%CI 0.15-0.96;p=0.04),质子泵抑制剂再摄取风险相似。MSA组出院后不良事件较少,主要由胃底折叠术后更高的自限性吞咽困难和腹胀/气胀驱动。
要点
- MSA较胃底折叠术显著降低中期手术翻修风险(HR 0.38,p=0.04)。
- MSA与胃底折叠术的PPI再摄取风险无显著差异(p=0.12)。
- MSA组装置取出率为4%(5/141)。
核心结论
- MSA较胃底折叠术降低再手术风险,并可能减少出院后不良事件。
研究设计与样本
- 回顾性单中心分析2015年1月至2020年6月连续MSA和Nissen胃底折叠术病例,均因食管裂孔疝所致药物治疗抵抗的反流行手术(含裂孔修补)。
- 从411例合格患者中,经倾向性评分匹配纳入141例MSA和141例胃底折叠术患者进行分析。
- 患者平均年龄55±12岁,超重(BMI 28±5),平均随访3.9年。
主要发现
- MSA组年手术翻修风险为1.2%,胃底折叠术组为3.0%/年(HR 0.38;95%CI 0.15-0.96;p=0.04)。
- MSA组年PPI再摄取风险为2.6%,胃底折叠术组为4.2%/年(HR 0.59;95%CI 0.30-1.16;p=0.12)。
- 初次住院期间不良事件率相似(MSA vs 胃底折叠术:1% vs 3%,p=0.68)。
- 出院后不良事件MSA组24%,胃底折叠术组33%(p=0.11),主要因胃底折叠术后自限性吞咽困难(1% vs 9%,p<0.01)和腹胀/气胀(10% vs 18%,p=0.06)更高。
- 需诊断性内镜的吞咽困难(11% vs 8%,p=0.54)或需手术翻修的吞咽困难(2% vs 1%,p=1.0)差异无统计学意义。
临床怎么用
- 对于食管裂孔疝相关药物治疗抵抗的反流患者,MSA可作为胃底折叠术的替代选择,中期再手术风险更低。
- 术前严重吞咽困难/动力障碍患者被分配至不同治疗路径并排除,MSA适用人群需排除此类患者。
- MSA术后需关注装置取出风险(4%)及出院后不良事件,胃底折叠术后需关注吞咽困难和腹胀/气胀。
局限性
- 回顾性单中心设计。
- 术前严重吞咽困难/动力障碍患者被排除,可能限制外推性。
- 需随机头对头研究比较现有手术选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An increasing number of reflux patients opt for magnetic sphincter augmentation (MSA) instead of fundoplication. However, few studies compare the medium-term efficacy and safety of the procedures. METHODS: We conducted a retrospective single-center analysis of consecutive MSA and Nissen fundoplication cases between 01/2015 and 06/2020. Patients underwent surgery, including hiatoplasty, for medical treatment-resistant reflux due to hiatal hernia. Surgical revision and proton pump inhibitor (PPI) reuptake rates were the primary outcomes. We also compared adverse event rates. Patients with severe preoperative dysphagia/motility disorders were assigned different treatment pathways and excluded from the analysis. We used propensity-score matching to reduce confounding between treatments. RESULTS: Out of 411 eligible patients, 141 patients who underwent MSA and 141 with fundoplication had similar propensity scores and were analyzed. On average, patients were 55 ± 12 years old and overweight (BMI: 28 ± 5). At 3.9 years of mean follow-up, MSA was associated with lower surgical revision risk as compared to fundoplication (1.2% vs 3.0% per year, respectively; HR: 0.38; 95% CI 0.15-0.96; p = 0.04), and similar PPI-reuptake risk (2.6% vs 4.2% per year; HR: 0.59; 95% CI 0.30-1.16; p = 0.12). Adverse event rates during primary stay were similar (MSA vs. fundoplication: 1% vs. 3%, p = 0.68). Fewer patients experienced adverse events in the MSA group after discharge (24% vs. 33%, p = 0.11), driven by higher rates of self-limiting dysphagia (1% vs. 9%, p < 0.01) and gas/bloating (10% vs. 18%, p = 0.06) after fundoplication. Differences between MSA and fundoplication in dysphagia requiring diagnostic endoscopy (11% vs. 8%, p = 0.54) or surgical revision (2% vs. 1%, p = 1.0) were non-significant. The device explantation rate was 4% (5/141). CONCLUSION: MSA reduces the re-operation risk compared to fundoplication and may decrease adverse event rates after discharge. Randomized head-to-head studies between available surgical options are needed.
引用
- Ibach MJ, Dahlke PM, Wiegrebe S, et al. Medium-term outcomes after magnetic sphincter augmentation vs. fundoplication for reflux disease due to hiatal hernia: a propensity-score matched comparison in 282 patients. Surg Endosc. 2024. PMID: 39014181. doi:10.1007/s00464-024-11011-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。